FDA approves Moderna's mRNA seasonal influenza vaccine for adults 50 and older, marking a significant step for mRNA technology beyond COVID-19.

Expert oncologists discuss managing adverse events in multiple myeloma patients with bispecific antibodies and CAR T-Cell therapies, including cytokine release

FDA approves Moderna's mRNA seasonal influenza vaccine for adults 50 and older, marking a significant step for mRNA…

Expert oncologists discuss managing adverse events in multiple myeloma patients with bispecific antibodies and CAR T-Cell therapies, including…

Erica Schwartz confirmed as new CDC director, marking a significant transition for the agency with its first permanent…

Narcolepsy type 1 treatment approved by FDA with oveporexton tablets targeting orexin signaling loss effectively.

Discover how pafolacianine, the first FDA-approved fluorescent probe for intraoperative tumor detection, works and its clinical impact on…

See how Oncology AI and smart scheduling increased patient volume significantly without adding new infrastructure or clinic operational…

Pharmacists play a critical role in optimizing therapy for patients with chronic kidney disease using SGLT2 inhibitors and…

OTC pain relief gets a boost as the FDA approves an acetaminophen‑naproxen combo, offering a new over‑the‑counter option…

Oncology infusion staffing trends reveal how smoother patient flow lets nurses optimize schedules, boosting efficiency and patient care…

Lung cancer remains a significant health concern with high mortality rates, emphasizing the importance of early detection and…